文献速递胃肠外科围术期管理与 ERAS急腹症与外科感染

大型胃肠手术围术期使用非甾体抗炎药与急性肾损伤的前瞻性多中心倾向匹配队列研究

Perioperative Nonsteroidal Anti-inflammatory Drugs (NSAID) Administration and Acute Kidney Injury (AKI) in Major Gastrointestinal Surgery: A Prospective, Multicenter, Propensity Matched Cohort Study.
PubMed 文献 · Ann Surg · 2020-10-14

早期术后使用NSAID(术后0-3天)占19.8%,倾向评分匹配后早期使用NSAID与急性肾损伤无显著关联(调整OR 0.80,95%CI 0.63-1.00,P=0.057),且与吻合口漏无关(调整OR 0.85,95%CI 0.58-1.21,P=0.382)。结论认为在选定患者中早期术后使用NSAID是安全的。

要点

  • 大型胃肠手术后早期(0-3天)使用NSAID未显著增加急性肾损伤风险。
  • 有胃肠吻合的患者中,NSAID使用与吻合口漏无显著关联。
  • 亚组分析按剂量和时机分层结果一致,支持特定患者中的安全性。

核心结论

  • 在选定的大型胃肠手术患者中,早期术后使用NSAID是安全的。
  • 倾向评分匹配后,早期使用NSAID与急性肾损伤无显著关联(调整OR 0.80,95%CI 0.63-1.00,P=0.057)。
  • 在有胃肠吻合的患者中,NSAID使用与吻合口漏无显著关联(调整OR 0.85,95%CI 0.58-1.21,P=0.382)。

研究设计与样本

  • 暴露定义为术后0-3天使用NSAID,主要结局为术后7天急性肾损伤发生率,采用倾向评分匹配平衡组间并估计OR及95%CI。

主要发现

  • 总体19.8%(1039/5240)的患者接受了早期NSAID。
  • 早期NSAID组急性肾损伤发生率为10.6%,无NSAID组为14.9%。
  • 接受吻合的患者中,NSAID组吻合口漏发生率为4.8%,无NSAID组为6.0%。
  • 倾向评分匹配后,早期使用NSAID与急性肾损伤无显著关联(调整OR 0.80,95%CI 0.63-1.00,P=0.057)。
  • 在有胃肠吻合的患者中,NSAID使用与吻合口漏无显著关联(调整OR 0.85,95%CI 0.58-1.21,P=0.382)。

临床怎么用

  • 对于选定的大型胃肠手术患者,可考虑术后早期使用NSAID作为镇痛的一部分,但需个体化评估风险。
  • 使用NSAID时仍应关注肾功能和吻合口情况,尤其是高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to determine the relationship between early postoperative nonsteroidal anti-inflammatory drug (NSAID) administration and postoperative acute kidney injury (AKI) and anastomotic leak. SUMMARY BACKGROUND DATA: NSAIDs have analgesic, opioid-sparing, and anti-inflammatory effects. However, their postoperative use is limited by concerns around increased risk of AKI and anastomotic leak. METHODS: A secondary analysis of a multicenter, prospective cohort study including patients undergoing elective or emergency major gastrointestinal surgery from September to December 2015 across 173 hospitals in the United Kingdom and ireland. Exposure to early postoperative NSAIDs was defined as NSAID administration on postoperative days 0 to 3. The primary outcome was the 7-day postoperative AKI rate. Propensity score matching was used to balance treatment groups and estimate treatment effects that are presented as odds ratios, alongside the corresponding 95% confidence interval (CI). RESULTS: Overall 19.8% (1039/5240) of patients received early NSAIDs. AKI rates were 10.6% in the early NSAID group and 14.9% in the no NSAID group. The anastomotic leak rate in patients who received an anastomosis was 4.8% in the NSAIDs group and 6.0% in the no NSAIDs group. Following propensity score matching, early use of NSAIDs was not significantly associated with AKI (adjusted odds ratio 0.80, 95% CI 0.63-1.00, P = 0.057). This finding was consistent in subgroup analyses by NSAID dosage and timing. In patients who had a gastrointestinal anastomosis, NSAIDs were not associated with anastomotic leak (adjusted odds ratio 0.85, 95% CI 0.58-1.21, P = 0.382). CONCLUSIONS: Administration of NSAIDs in the early postoperative period is safe in selected patients following major gastrointestinal surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Perioperative Nonsteroidal Anti-inflammatory Drugs (NSAID) Administration and Acute Kidney Injury (AKI) in Major Gastrointestinal Surgery: A Prospective, Multicenter, Propensity Matched Cohort Study. Ann Surg. 2020. PMID: 33074883. doi:10.1097/SLA.0000000000004314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。